<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Information Statements Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Health Systems Design Corporation
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
421964 10 7
---------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement: / /. (A
fee is not required only if the filling person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
1. J. Matthew Mackowski
2. Not Applicable
3.
<PAGE>
4. USA
5. 1,357,600 Shares
6. Not Applicable
7. 1,357,600 Shares
8. Not Applicable
9. 1,357,600 Shares
10. Not Applicable
11. Approximately 20.9%
12. IN
Item 1(a). Name of Issuer:
Health Systems Design Corporation
Item 1(b). Address of Issuer's Principal Executive Offices:
1330 Broadway
Oakland, CA 94612
Item 2(a). Name of Person Filing:
J. Matthew Mackowski
Item 2(b). Address of Principal Business Office or, if none, Residence:
343 Sansome Street, Suite 1215
San Francisco, CA 94104
Item 2(c). Citizenship:
USA
Item 2(d). Title of Class of Securities:
Common Stock
Item 2(e). CUSIP Number:
421964 10 7
Item 3. Rule 13d-1(b) or 13d-2(b):
Not Applicable
2
<PAGE>
Item 4. Ownership:
(a) Amount beneficially owned:
1,357,600 Shares
(b) Percent of class:
Approximately 20.9%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote of:
1,357,600 Shares
(ii) shared power to vote or to direct the vote of:
Not Applicable
(iii) sole power to dispose or to direct the disposition of:
1,357,600 Shares
(iv) shared power to dispose or to direct the disposition of:
Not Applicable
Item 5. Ownership of Five Percent or Less of a Class:
Not Applicable
Item 6. Ownership of More than Five Percent on Behalf of Another Person:
Of the 1,357,600 shares shown as owned by Mr. Mackowski, 1,297,600 are
held in the name of Mr. Mackowski and 60,000 shares are issuable upon exercise
of outstanding warrants which are immediately exercisable by Mr. Mackowski.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company:
Not Applicable
Item 8. Identification and Classification of Members of the Group:
Not Applicable
Item 9. Notice of Dissolution of Group:
3
<PAGE>
Not Applicable
Item 10. Certification:
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
____________________
Date
/s/ J. Matthew Mackowski
____________________
Signature
J. Matthew Mackowski
Director
____________________
Name/Title
4
